Eco-Med Pharmaceuticals Inc. yesterday recalled a nonsterile ultrasound gel distributed under various brand names, including EcoGel and MediChoice, instructing health care facilities to immediately destroy or return the products due to contamination with the bacteria Burkholderia cepacia complex (Bcc).

The Centers for Disease Control and Prevention is assisting the Food and Drug Administration and several state and local health departments with an ongoing investigation of Bcc infections in health care facilities. It said patients have developed Bcc infections (including bloodstream infections) after ultrasound-guided procedures that used the MediChoice M500812 ultrasound gel.

CDC advises health care facilities to always use single-use, sterile ultrasound gel packets for ultrasonography used in preparation for or during transcutaneous procedures, such as placement of central and peripheral intravenous lines, amniocentesis and paracentesis. This includes avoiding nonsterile ultrasound gel for visualization prior to such procedures (e.g., vein marking, visualizing ascites). 

Health care facilities should report any patient infections to FDA’s MedWatch program

Related News Articles

Headline
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community HealthVickie Johnson, executive vice president and chief community officer at…
Headline
As part of Community Health Improvement Week June 9-13, two experts from Corewell Health share how an impactful health care ecosystem model is supporting local…
Headline
With June 9-13 being Community Health Improvement Week, three experts from HonorHealth discuss how the health care network is addressing community needs beyond…
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…